BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

973 related articles for article (PubMed ID: 33582177)

  • 1. Extracellular vesicles from GPNMB-modified bone marrow mesenchymal stem cells attenuate bone loss in an ovariectomized rat model.
    Huang B; Su Y; Shen E; Song M; Liu D; Qi H
    Life Sci; 2021 May; 272():119208. PubMed ID: 33582177
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Extracellular vesicles from bone marrow mesenchymal stem cells alleviate osteoporosis in mice through USP7-mediated YAP1 protein stability and the Wnt/β-catenin pathway.
    Wang X; Zou C; Hou C; Bian Z; Jiang W; Li M; Zhu L
    Biochem Pharmacol; 2023 Nov; 217():115829. PubMed ID: 37748664
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Foxf1 knockdown promotes BMSC osteogenesis in part by activating the Wnt/β-catenin signalling pathway and prevents ovariectomy-induced bone loss.
    Shen G; Ren H; Shang Q; Zhao W; Zhang Z; Yu X; Tang K; Tang J; Yang Z; Liang D; Jiang X
    EBioMedicine; 2020 Feb; 52():102626. PubMed ID: 31981979
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human umbilical cord mesenchymal stromal cells-derived extracellular vesicles exert potent bone protective effects by CLEC11A-mediated regulation of bone metabolism.
    Hu Y; Zhang Y; Ni CY; Chen CY; Rao SS; Yin H; Huang J; Tan YJ; Wang ZX; Cao J; Liu ZZ; Xie PL; Wu B; Luo J; Xie H
    Theranostics; 2020; 10(5):2293-2308. PubMed ID: 32089743
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Morusin induces osteogenic differentiation of bone marrow mesenchymal stem cells by canonical Wnt/β-catenin pathway and prevents bone loss in an ovariectomized rat model.
    Chen M; Han H; Zhou S; Wen Y; Chen L
    Stem Cell Res Ther; 2021 Mar; 12(1):173. PubMed ID: 33712069
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chrysosplenetin promotes osteoblastogenesis of bone marrow stromal cells via Wnt/β-catenin pathway and enhances osteogenesis in estrogen deficiency-induced bone loss.
    Hong G; He X; Shen Y; Chen X; Yang F; Yang P; Pang F; Han X; He W; Wei Q
    Stem Cell Res Ther; 2019 Aug; 10(1):277. PubMed ID: 31464653
    [TBL] [Abstract][Full Text] [Related]  

  • 7. METTL3-m
    Wu T; Tang H; Yang J; Yao Z; Bai L; Xie Y; Li Q; Xiao J
    Cell Prolif; 2022 May; 55(5):e13234. PubMed ID: 35470497
    [TBL] [Abstract][Full Text] [Related]  

  • 8. LncRNA HOTAIR inhibited osteogenic differentiation of BMSCs by regulating Wnt/β-catenin pathway.
    Shen JJ; Zhang CH; Chen ZW; Wang ZX; Yang DC; Zhang FL; Feng KH
    Eur Rev Med Pharmacol Sci; 2019 Sep; 23(17):7232-7246. PubMed ID: 31539110
    [TBL] [Abstract][Full Text] [Related]  

  • 9. microRNA-935-modified bone marrow mesenchymal stem cells-derived exosomes enhance osteoblast proliferation and differentiation in osteoporotic rats.
    Zhang Y; Cao X; Li P; Fan Y; Zhang L; Ma X; Sun R; Liu Y; Li W
    Life Sci; 2021 May; 272():119204. PubMed ID: 33581127
    [TBL] [Abstract][Full Text] [Related]  

  • 10. BMSC-derived extracellular vesicles promoted osteogenesis via Axin2 inhibition by delivering MiR-16-5p.
    Duan J; Li H; Wang C; Yao J; Jin Y; Zhao J; Zhang Y; Liu M; Sun H
    Int Immunopharmacol; 2023 Jul; 120():110319. PubMed ID: 37216799
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Extracellular vesicles derived from bone marrow mesenchymal stem cells loaded on magnetic nanoparticles delay the progression of diabetic osteoporosis via delivery of miR-150-5p.
    Xu C; Wang Z; Liu Y; Wei B; Liu X; Duan K; Zhou P; Xie Z; Wu M; Guan J
    Cell Biol Toxicol; 2023 Aug; 39(4):1257-1274. PubMed ID: 36112264
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Inhibition of MicroRNA-139-5p Promoted Osteoporosis of Bone Marrow-Derived Mesenchymal Stem Cells by Targeting Wnt/Beta-Catenin Signaling Pathway by NOTCH1.
    Feng Y; Wan P; Yin L; Lou X
    J Microbiol Biotechnol; 2020 Mar; 30(3):448-458. PubMed ID: 31752063
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Methyl-CpG-binding protein 2 promotes osteogenic differentiation of bone marrow mesenchymal stem cells through regulating forkhead box F1/Wnt/β-Catenin axis.
    Ji W; Sun X
    Bioengineered; 2022 Jan; 13(1):583-592. PubMed ID: 34967263
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The lncRNA H19/miR-541-3p/Wnt/β-catenin axis plays a vital role in melatonin-mediated osteogenic differentiation of bone marrow mesenchymal stem cells.
    Han H; Tian T; Huang G; Li D; Yang S
    Aging (Albany NY); 2021 Jul; 13(14):18257-18273. PubMed ID: 34311444
    [TBL] [Abstract][Full Text] [Related]  

  • 15. microRNA-148a-3p in extracellular vesicles derived from bone marrow mesenchymal stem cells suppresses SMURF1 to prevent osteonecrosis of femoral head.
    Huang S; Li Y; Wu P; Xiao Y; Duan N; Quan J; Du W
    J Cell Mol Med; 2020 Oct; 24(19):11512-11523. PubMed ID: 32871042
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hmga1-overexpressing lentivirus protects against osteoporosis by activating the Wnt/β-catenin pathway in the osteogenic differentiation of BMSCs.
    Wu Z; Zhu J; Wen Y; Lei P; Xie J; Shi H; Wu R; Lou X; Hu Y
    FASEB J; 2023 Sep; 37(9):e22987. PubMed ID: 37555233
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gentiopicroside promotes the osteogenesis of bone mesenchymal stem cells by modulation of β-catenin-BMP2 signalling pathway.
    Jiang H; Zhong J; Li W; Dong J; Xian CJ; Shen YK; Yao L; Wu Q; Wang L
    J Cell Mol Med; 2021 Dec; 25(23):10825-10836. PubMed ID: 34783166
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bone-Targeted Extracellular Vesicles from Mesenchymal Stem Cells for Osteoporosis Therapy.
    Wang Y; Yao J; Cai L; Liu T; Wang X; Zhang Y; Zhou Z; Li T; Liu M; Lai R; Liu X
    Int J Nanomedicine; 2020; 15():7967-7977. PubMed ID: 33116512
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization and immunogenicity of bone marrow-derived mesenchymal stem cells under osteoporotic conditions.
    Huang Y; Yin Y; Gu Y; Gu Q; Yang H; Zhou Z; Shi Q
    Sci China Life Sci; 2020 Mar; 63(3):429-442. PubMed ID: 31879847
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A novel therapeutic approach with Caviunin-based isoflavonoid that en routes bone marrow cells to bone formation via BMP2/Wnt-β-catenin signaling.
    Kushwaha P; Khedgikar V; Gautam J; Dixit P; Chillara R; Verma A; Thakur R; Mishra DP; Singh D; Maurya R; Chattopadhyay N; Mishra PR; Trivedi R
    Cell Death Dis; 2014 Sep; 5(9):e1422. PubMed ID: 25232676
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 49.